Table 2 Proportion of patients with no problem on EQ-5D from baseline to day 14 and day 90*
Items | From baseline to Day 14 | Â | From baseline to Day 90 | |||||
|---|---|---|---|---|---|---|---|---|
GDLM group (N = 1615) | Placebo group (N = 1604) | Odds ratio (95% CI) | P value | GDLM group (N = 1615) | Placebo group (N = 1604) | Odds ratio (95% CI) | P value | |
Mobility | 670 (41.5) | 496 (30.9) | 1.58 (1.37–1.83) |  < 0.0001 | 1046 (64.8) | 849 (52.9) | 1.63 (1.42–1.88) | 0.0190 |
Usual activities | 543 (33.6) | 423 (26.4) | 1.41 (1.22–1.65) |  < 0.0001 | 891 (55.2) | 723 (45.1) | 1.50 (1.31–1.72) |  < 0.0001 |
Self-care | 542 (33.6) | 423 (26.4) | 1.41 (1.21–1.64) |  < 0.0001 | 890 (55.1) | 722 (45.0) | 1.50 (1.31–1.72) |  < 0.0001 |
Pain/discomfort | 1199 (74.2) | 1060 (66.1) | 1.48 (1.27–1.72) |  < 0.0001 | 1377 (85.3) | 1237 (77.1) | 1.72 (1.43–2.06) |  < 0.0001 |
Anxiety/depression | 1189 (73.6) | 1063 (66.3) | 1.42 (1.22–1.65) |  < 0.0001 | 1386 (85.8) | 1235 (77.0) | 1.81 (1.51–2.17) |  < 0.0001 |